Parkinson’s podcast: stopping disease progression

News

Author: Geoffrey ChangPublished: 9 July 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Portland-Countdown-Show-2

In the second episode of the Portland Countdown podcast series, Dr Patrik Brundin and Dr Kimberley Gannon discuss how to stop ‘bad’ proteins attacking brain cells

Stopping disease progression: alpha synuclein

Special Guests: Patrik Brundin, MD, PhD and Kimberley Gannon, PhD

Basic researchers are hard at work trying to understand the pathology of Parkinson’s and discover new drug targets. One likely bad actor is a protein called alpha-synuclein.

Hosted by Dave Iverson and Jon Palfreman, Emmy award-winning journalists living with Parkinson’s disease, this episode looks into what we know about how alpha-synuclein kills brain cells and what might be done to stop it, with Dr Patrik Brundin and Dr Kimberley Gannon on hand to offer their expert opinions.

The aim of the Portland Countdown series is to give listeners new perspectives on the latest advances in Parkinson’s research and treatment.

The shows, developed by the World Parkinson Coalition, are aired online on the first Tuesday of every month from June 2015 to September 2016 – when the 4th World Parkinson Congress takes place in Portland, Oregon, USA. The entire series of podcasts will also be downloadable for free.


The full schedule of show topics and guest speaker profiles is available here

 

Go Back

Share this story

Comments


Related articles


kinetics-lead

Europe

An inspiring play about Parkinson’s and Parkour is coming to a theatre near you

What can a teenage boy and woman with Parkinson’s have in common?

READ MORE
Luxembourg pillow fight for Parkinson's lead

Europe

Luxembourgers ruffle some feathers for Parkinson’s awareness

Flash mob pillow fight for Parkinson’s in Luxembourg

READ MORE
Maria Alice and family lead

sponsored article

Advances

How DBS can help improve Parkinson’s mobility issues

Learn about the ACTIVA™ RC Neurostimulator from Medtronic

READ MORE